FTSE MIB
34.249,77 +310,02 (+0,91%) Dow Jones
38.239,66 +153,86 (+0,40%) Nasdaq
15.927,90 +316,14 (+2,03%) Nikkei 225
37.934,76 +306,28 (+0,81%) Petrolio
83,66 +0,09 (+0,11%) Bitcoin EUR
59.756,45 +894,30 (+1,52%)
Enovis Corporation (0I1B.L)
| Chiusura precedente | 55,66 |
| Aperto | 55,41 |
| Denaro | N/D x N/D |
| Lettera | N/D x N/D |
| Min-Max giorno | 55,41 - 55,41 |
| Intervallo di 52 settimane | 43,31 - 65,36 |
| Volume | |
| Media Volume | 26 |
| Capitalizzazione | N/D |
| Beta (5 anni mensile) | 2,07 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | N/D |
| Prossima data utili | 02 mag 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
GlobeNewswireEnovis to Host Third Quarter 2023 Results Conference Call on November 7th
Wilmington, DE, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it will host an investor conference call and live webcast to discuss its third quarter 2023 financial results on Tuesday, November 7, 2023 at 8:00 a.m. Eastern Time and will issue a press release earlier that morning. A presentation related to the call will be available at www.enovis.com in the “Investors” section. Conference call/Webca
- GlobeNewswire
Enovis to Acquire LimaCorporate S.p.A.
Creating a high-growth, global reconstruction leader with ~$1 billion in annual revenueAttractive margin profile and meaningful synergies expected to increase profitability Wilmington, DE, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV, “Enovis” or the “Company”), an innovation-driven, medical technology growth company, today announced a definitive agreement to acquire LimaCorporate S.p.A. (“Lima”), a privately held global orthopedic leader focused on restoring motion through
GlobeNewswireEnovis Debuts New Foot & Ankle Offerings at the AOFAS Annual Meeting
New solutions in Percutaneous and Open Bunion procedures, External Fixation, and Patient Specific Instrumentation, will be featured as part of the company’s growing evidence based, high tech portfolio. Enovis Foot & Ankle at AOFAS 2023 Products featured by Enovis™ Foot & Ankle at the AOFAS Annual Meeting Wilmington, DE, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Today, Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology company, announced it will showcase new products from its rec
